Fetal Type Lymphocytes in Insulin Dependent Diabetes Mellitus

References

• Powers A. C., Eisenbarth G. S. Autoimmunity to islet cells in diabetes mellitus. Annu. Rev. Med. 1985; 36: 533–544
   PubMed Web of Science ®Google Scholar
• Thai A. Ch., Eisenbarth G. S. Natural history of IDDM. Diabetes Rev. 1993; 1: 1–14
   Google Scholar
• Castano L., Eisenbarth G. S. Type I diabetes: a chronic autoimmune disease of human, mouse and rat. Ann. Rev. Immunol. 1990; 8: 647–679
   PubMed Web of Science ®Google Scholar
• Roep B. O. T-cell responses to autoantigens in IDDM. The search for the Holy-Grail. Diabetes 1996; 45: 1147–1156
   PubMed Web of Science ®Google Scholar
• Atkinson M. A., Maclaren N. K. Islet cell autoantigens in insulin-dependent diabetes. J. Clin. Invest. 1993; 92: 1608–1616
   PubMed Web of Science ®Google Scholar
• Harrison L. C. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol. Today 1992; 13(9)348–352
   PubMedGoogle Scholar
• Kroemer G., Martinez A. C. Mechanisms of self tolerance. Immunol. Today 1992; 13: 401–404
   PubMedGoogle Scholar
• Miller J. F., Morahan G. Peripheral tolerance. Annu. Rev. Immunol. 1992; 10: 51–69
   PubMed Web of Science ®Google Scholar
• Signorelli K., Benoist C., Mathis D. Why is clonal deletion of neonatal thymocytes defective?. Eur. J. Immunol. 1992; 22: 2487–2493
   PubMed Web of Science ®Google Scholar
• Cohen I. R. The cognitive principle challenges clonal selection. Immunol. Today 1992; 13: 441–444
   PubMedGoogle Scholar
• Cohen I. R. The cognitive paradigm and the immunological homunculus. Immunol. Today 1992; 13: 490–494
   PubMedGoogle Scholar
• Cohen I. R. The self, the world and the autoimmunity. Sci. Am. 1988; 258(4)52–56
   PubMed Web of Science ®Google Scholar
• Iwatani Y., Amino N., Kaneda T. Marked increase of CDS + B cells in hyperthyroid Graves' disease. Clin. Exp. Immunol. 1989; 78: 196–200
   PubMed Web of Science ®Google Scholar
• Dauphinee M., Tovar Z., Talal N. B cells expressing CD5 are increased in Sjögren's syndrome. Arthritis Rheum. 1988; 31(5)642–647
   PubMedGoogle Scholar
• Mix C., Olsson J., Correale J., Baig S., Kostulas V., Olsson O., Link H. B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis. Clin. Exp. Immunol. 1990; 79: 21–27
   PubMed Web of Science ®Google Scholar
• Hassan J., Yanni G., Hegarty V., Feighery C., Bresnihan B., Whelan A. Increased numbers of CD5+ B cells and T cell receptor (TCR) gamma delta+ T cells are associated with younger age of onset in rheumatoid arthritis (RA). Clin. Exp. Immunol. 1996; 103(3)353
   PubMed Web of Science ®Google Scholar
• Plater-Zyberk C., Brennan F. M., Feldmann M., Maini R. N. “Fetal type” B and T lymphocytes in rheumatoid arthritis and primary Sjögren's syndrome. J. Autoimmun. 1989; 2: 233–241
   PubMed Web of Science ®Google Scholar
• Munoz A., Gallart T., Usac E. F., Alvarez F. J., Vinas O., Somoza N., Barcelo J., Gomis R. Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM. Diabetologia 1995; 38: 62–72
   PubMed Web of Science ®Google Scholar
• Nikoletti F., Meroni P. L., Barrallini W., Steinsvag P. O., Di Mauro M., Lunette M., Pagona M., Consoli U., Zanussi C. Enhanced percentage of CD5+ B lymphocytes in newly diagnosed IDDM patients. Immunol. Lett. 1989; 23: 211–216
   Web of Science ®Google Scholar
• Munoz A., Gallart T., Vinas O., Gomis R. Increased CD5+ B lymphocytes in type 1 diabetes. Clin. Exp. Immunol. 1991; 83: 304–308
   PubMed Web of Science ®Google Scholar
• Schatz D. A., Lang F., Cantor A. B., Riley W. J., Maclaren N. K., Sleasman W. J., Barrett D. J. CD5+ B lymphocytes in high islet cell antibody positive and newly diagnosed IDDM subjects. Diabetes 1991; 40: 1314–1318
   PubMed Web of Science ®Google Scholar
• Smerdon R. A., Peakman M., Hussain M. J., Wong S. F. CD5+ B-cells at the onset of type 1 diabetes and in the prediabetic period. Diab. Care 1994; 17(7)657–664
   PubMed Web of Science ®Google Scholar
• Goldrath A. W., Barber L., Chen K. E., Alters S. E. Differences in adhesion markers, and TCR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse. J. Autoimmun. 1995; 8(2)209–220
   PubMed Web of Science ®Google Scholar
• Santamaria P., Lewis C., Jessurun J., Sutherlad D. E., Barbosa J. E. Skewed T-cell receptor usage and junctional heterogeneity among isletitis alpha beta and gamma delta T-cells in human IDDM. Diabetes 1994; 43(4)599–606
   PubMed Web of Science ®Google Scholar
• National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039–1057
   PubMed Web of Science ®Google Scholar
• Bingley P. J., Christie M. R., Bonifacio E., Bonfanti R., Shattock M., Fonte M. T., Bottazzo G. F., Gale A. E. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43: 1304–1310
   PubMed Web of Science ®Google Scholar
• Bonaficio E., Bingley P. J., Shattock M., Dean B. M., Dunger D., Gale A. E. Quantification of islet-cell antibodies and prediction of insulin dependent diabetes. Lancer 1990; 335: 147–149
   PubMed Web of Science ®Google Scholar
• Hanenberg H., Kolb-Bachofen V., Kantwerk-Funke G., Kolb H. Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of prediabetic BB rats. Diabetologia 1989; 32: 126–134
   PubMed Web of Science ®Google Scholar
• Mandrup P. T. The role of IL1 in the pathogenesis of IDDM. Diabetologia 1996; 39: 1005–1029
   PubMedGoogle Scholar
• Mandrup P. T., Helqvist S., Wogenseu L. D., Molvig J., Pociot F., Johannesen J., Nerup J. Cytokines and free radicals as effector molecules in the destruction of pancreatic B-cells. Curr. Top. Microbiol. Immunol. 1990; 164: 169–193
   PubMed Web of Science ®Google Scholar
• Calcinaro F., Hao L., Chase H. P., Klingensmith G., Lafferty K. J. Detection of cell mediated immunity in type I diabetes mellitus. J. Autoimmun. 1992; 5: 137–147
   PubMed Web of Science ®Google Scholar
• Lehmann P. V., Sercarz E. E., Forsthuber T., Dayan C. M., Gammon G. Determinant spreading and dynamics of the autoimmune T-cell repertoire. Immunol. Today 1993; 14(5)203–208
   PubMedGoogle Scholar
• Yau-Hua S., Yanxin L., Maclaren N. K. The nature of autoantigens targeted in autoimmune endocrine diseases. Immunol. Today 1996; 7(5)232–238
   Google Scholar
• Elias D., Cohen I. R. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes 1995; 44: 1132–1138
   PubMed Web of Science ®Google Scholar
• Born W., Harp M. D., Dallas A., Reardon C., Kubo R., Shinnick T., Brennan P., O'Brien R. Recognition of heat shock proteins and γ/δ T cell function. Immunol. Today 1990; 11: 40–43
   PubMedGoogle Scholar
• Groh V., Porcelli S., Fabbi M., Lanier L. L., Picker L. J., Anderson T., Warnke R. A., Bhan A. K., Strominger J. L., Brenner M. B. Human lymphocytes bearing T cell receptor gammaidelta are phenotypically diverse and evenly distributed throughout the lymphoid system. J. Exp. Med. 1989; 169: 1277–1294
   PubMed Web of Science ®Google Scholar
• Gadol N., Auk K. A. Phenotypic and functional characterization of human Leu 1 (CDS) B cells. Immunol. Rev. 1986; 93: 23–34
   PubMed Web of Science ®Google Scholar
• Durandy A., Thulillier L., Forveille M., Fischer A. Phenotypic and functional characteristics of human newborns B lymphocytes. J. Immunol. 1990; 144: 60–65
   PubMed Web of Science ®Google Scholar
• Kantor A. B. The development and repertoire of BI cells (CD5 B cells). Immunol. Today 1991; 12(11)389–391
   PubMedGoogle Scholar
• Avrameas S. Natural autoantibodies: from “horror auto-toxicus” to “gnothi seauton”. Immunol. Today 1991; 12(5)154–159
   PubMedGoogle Scholar